Merilee Raines - 05 Aug 2025 Form 4 Insider Report for WATTS WATER TECHNOLOGIES INC (WTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Aug 2025, 11:56:04 UTC
Prior SEC filing
13 Jun 2025
Next SEC filing
22 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Seth M. Kipp, Attorney-in-Fact

Key filing fact

Merilee Raines filed Form 4 for WATTS WATER TECHNOLOGIES INC (WTS) on 05 Aug 2025.

Key facts

  • This page summarizes Merilee Raines's Form 4 filing for WATTS WATER TECHNOLOGIES INC (WTS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Aug 2025, 11:56.

Change

  • Previous filing in this sequence was filed on 13 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001023869 Primary reporting owner

RAINES MERILEE

Relationship
Director
Address
815 CHESTNUT STREET, NORTH ANDOVER
Signature
/s/ Seth M. Kipp, Attorney-in-Fact
Signature date
05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WTS transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+516
Change %
+2.5%
Price
$0.000000
Shares after
21,214
Date
05 Aug 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $130,000 by a 30-day trailing average stock price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .